Evidence in context
Two trials. No head-to-head answer. →
Why a “19.7% vs 17.5%” graphic cannot establish a winner.
An independent guide to a triple-receptor research candidate: what the obesity trial found, how to read its estimates, and where the evidence stops.
Why a “19.7% vs 17.5%” graphic cannot establish a winner.
Body weight change and placebo adjustment answer related but distinct questions.
A guide to model-based means, uncertainty, and the boundaries of a trial result.
A placebo-controlled study in China: what was measured, what changed, and what remains unresolved.
A companion UBT251 trial with a different population and a glycemic outcome.
UBT251 is a research candidate, not an approved medicine. This educational project distinguishes trial results from personal decisions. It does not provide medical advice or sourcing.
Read our editorial disclosures →